Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors

about

Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors

Item

http://www.wikidata.org/entity/Q59129210

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2019

@uk

name

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@en

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@nl

type

Item

label

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@en

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@nl

prefLabel

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@en

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@nl

P1476

Synthesis, preliminarily biolo ...... and cholinesterase inhibitors

@en

P2093

Cheng-Zhi Gao

http://www.w3.org/2001/XMLSchema#string

Qing-Ming Wu

http://www.w3.org/2001/XMLSchema#string

Qiong Yuan

http://www.w3.org/2001/XMLSchema#string

Wei Dong

http://www.w3.org/2001/XMLSchema#string

Xia-Min Hu

http://www.w3.org/2001/XMLSchema#string

Xianlin Han

http://www.w3.org/2001/XMLSchema#string

Yao Xu

http://www.w3.org/2001/XMLSchema#string

Zhen-Li Min

http://www.w3.org/2001/XMLSchema#string

Zhi-Wen Cui

http://www.w3.org/2001/XMLSchema#string

P2860

PARP inhibitors in the management of breast cancer: current data and future prospects

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering

PARP inhibitors stumble in breast cancer

LigPlot+: multiple ligand-protein interaction diagrams for drug discovery

PARP inhibition: PARP1 and beyond

4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.

Parthanatos, a messenger of death.

Delivering on the promise: poly ADP ribose polymerase inhibition as targeted anticancer therapy.

Nitric oxide (NO) releasing poly ADP-ribose polymerase 1 (PARP-1) inhibitors targeted to glutathione S-transferase P1-overexpressing cancer cells.

Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.

P304

150-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2018.1530224

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2019-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30427217

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

P932

6237161

http://www.w3.org/2001/XMLSchema#string